Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors

There is limited data on co-expression of FGFR/FGR amplifications and PI3K/ AKT/mTOR alterations in breast cancer. Tumors from patients with metastatic breast cancer referred to our Phase I Program were analyzed by next generation sequencing (NGS). Genomic libraries were selected for all exons of 23...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheler, Jennifer J., Atkins, Johnique T., Janku, Filip, Moulder, Stacy L., Stephens, Philip J., Yelensky, Roman, Valero, Vicente, Miller, Vincent, Kurzrock, Razelle, Meric-Bernstam, Funda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965259/
https://www.ncbi.nlm.nih.gov/pubmed/27489863
http://dx.doi.org/10.18632/oncoscience.307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965259/
https://www.ncbi.nlm.nih.gov/pubmed/27489863
http://dx.doi.org/10.18632/oncoscience.307

Ejemplares similares